EcoR1 Capital, LLC
31 holdingsFiling period: 2026-06-30Current AUM: $1.94Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ZYME | Zymeworks Inc | 22.97M | $600.4M | $662.7M | 34.17% | -- | 2026-06-30 |
| 2 | ANAB | Anaptysbio Inc | 7.88M | $531.9M | $391.1M | 20.16% | -- | 2026-06-30 |
| 3 | AKTS | Aktis Oncology Inc | 4.82M | $155.5M | $79.4M | 4.09% | -- | 2026-06-30 |
| 4 | CGON | CG Oncology Inc | 2.06M | $146.1M | $129.4M | 6.67% | +953.8K | 2026-06-30 |
| 5 | ETON | Eton Pharmaceuticals Inc | 2.17M | $78.6M | $111.1M | 5.73% | -- | 2026-06-30 |
| 6 | — | Crispr Therapeutics AG | 1.39M | $75.8M | $75.8M | 3.91% | -- | 2026-06-30 |
| 7 | ORIC | Oric Pharmaceuticals Inc | 6.73M | $72.9M | $60.6M | 3.12% | -- | 2026-06-30 |
| 8 | TRAX | First Tracks Biotherapeutics | 3.17M | $63.9M | $144.1M | 7.43% | -- | 2026-06-30 |
| 9 | GLPG | Lakefront Biotherapeutics NV | 1.67M | $50.0M | $50.0M | 2.58% | -- | 2026-06-30 |
| 10 | NGNE | Neurogene Inc | 1.27M | $40.0M | $34.3M | 1.77% | -- | 2026-06-30 |
| 11 | STOK | Stoke Therapeutics Inc | 735.0K | $24.0M | $19.2M | 0.99% | +635.0K | 2026-06-30 |
| 12 | FULC | Fulcrum Therapeutics Inc | 6.55M | $24.0M | $24.2M | 1.25% | -- | 2026-06-30 |
| 13 | LEGN | Legend Biotech Corp | 800.0K | $23.1M | $17.2M | 0.89% | -- | 2026-06-30 |
| 14 | BBOT | Bridgebio Oncology Therapeut | 2.82M | $21.5M | $7.6M | 0.39% | -- | 2026-06-30 |
| 15 | MBX | Mbx Biosciences Inc | 388.5K | $21.4M | $20.6M | 1.06% | -388,500 | 2026-06-30 |
| 16 | ZBIO | Zenas Biopharma Inc | 789.5K | $20.0M | $21.6M | 1.11% | -- | 2026-06-30 |
| 17 | ATRA | Atara Biotherapeutics Inc | 1.55M | $17.8M | $12.9M | 0.66% | +1.45M | 2026-06-30 |
| 18 | RLAY | Relay Therapeutics Inc | 697.9K | $13.1M | $13.1M | 0.68% | -1,206,814 | 2026-06-30 |
| 19 | AURA | Aura Biosciences Inc | 1.67M | $11.8M | $10.5M | 0.54% | -- | 2026-06-30 |
| 20 | ODTX | Odyssey Therapeutics Inc | 555.6K | $10.4M | $10.8M | 0.56% | -- | 2026-06-30 |
| 21 | EIKN | Eikon Therapeutics Inc | 732.6K | $9.6M | $4.1M | 0.21% | -- | 2026-06-30 |
| 22 | — | Pharvaris N V | 235.0K | $8.1M | $8.1M | 0.42% | -- | 2026-06-30 |
| 23 | — | Zura Bio Ltd | 1.18M | $7.0M | $7.0M | 0.36% | -- | 2026-06-30 |
| 24 | PHAT | Phathom Pharmaceuticals Inc | 625.0K | $6.8M | $3.7M | 0.19% | -- | 2026-06-30 |
| 25 | NRIX | Nurix Therapeutics Inc | 270.0K | $6.5M | $7.2M | 0.37% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2